OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CATX

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Perspective Therapeutics (CATX) Earnings Date & Reports

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CATX is expected to report earnings to rise 7.17% to -31 cents per share on November 18

Perspective Therapeutics CATX Stock Earnings Reports

Q3'25

Est.

$-0.31

Q2'25

Est.

$-0.29

Q1'25

Beat

by $0.06

Q4'24

Missed

by $0.30

Q3'24

Est.

$-0.21

The last earnings report on August 13 showed earnings per share of -28 cents, meeting the estimate of -28 cents. With 433.27K shares outstanding, the current market capitalization sits at 267.35M.

View a ticker or compare two or three

Compare

CATX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CATX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CATX showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a producer of therapeutic radioactive isotopes

Industry MedicalNursingServices

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2401 Elliott Avenue

Phone

+1 206 676-0900

Employees

119

Web

https://www.perspectivetherapeutics.com